BioNTech SE (BNTX) Non-Current Deferred Tax Liability (2020 - 2025)

BioNTech SE (BNTX) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $98.1 million in Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability rose 116.58% year-over-year to $98.1 million; the TTM figure through Dec 2025 stood at $98.1 million (up 116.58% YoY), while the FY2025 annual figure was $95.2 million, up 110.21% from the prior year.
• Non-Current Deferred Tax Liability advanced to $98.1 million in Q4 2025, from $28.3 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $107.1 million in Q2 2022 and bottomed at $4.9 million in Q2 2023.
• A 5-year average of $42.9 million and a median of $42.7 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2021 — Non-Current Deferred Tax Liability surged 31898.45% — and 2023, when it sank 95.43%.
• Year by year, Non-Current Deferred Tax Liability stood at $76.3 million in 2021, then sank by 91.71% to $6.3 million in 2022, then jumped by 575.28% to $42.7 million in 2023, then rose by 6.07% to $45.3 million in 2024, then surged by 116.58% to $98.1 million in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $98.1 million (Q4 2025), $28.3 million (Q3 2025), and $32.3 million (Q2 2025), per Business Quant data.

Peer Comparison